AI Portfolio Summary
In 2002 Q4, ORBIMED CAPITAL LLC maintained a portfolio of 28 distinct positions. The most significant new addition to the portfolio was Corp , which now represents 11.78% of the total fund value.
Total Positions
28
Quarter
2002 Q4
Top Holding
N/A (11.8%)
Top 10 Concentration
74.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-25 of 28
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
N/A
Corp ...
|
—
|
Unknown | 11.78% | — |
#1
Prev: #—
|
6.7 | 1,464,500 | no change |
NEW
|
1,464,500 | $24,120,315 | — | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | ||
|
PFE
Pfizer Inc. ...
|
Healthcare | 9.71% | — |
#2
Prev: #—
|
5.9 | 650,000 | no change |
NEW
|
650,000 | $19,870,500 | 2002 Q4 | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | |||
|
N/A
Orthovita Inc. ...
|
—
|
Unknown | 8.61% | — |
#3
Prev: #—
|
5.4 | 4,053,785 | no change |
NEW
|
4,053,785 | $17,633,965 | — | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | ||
|
AMGN
Amgen Inc. ...
|
Healthcare | 7.90% | — |
#4
Prev: #—
|
5.2 | 334,400 | no change |
NEW
|
334,400 | $16,164,896 | 2002 Q4 | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | |||
|
LLY
Eli Lilly & Com...
|
Healthcare | 7.13% | — |
#5
Prev: #—
|
4.9 | 230,000 | no change |
NEW
|
230,000 | $14,605,000 | 2002 Q4 | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | |||
|
DNA
Genentech Inc ...
|
Healthcare | 6.48% | — |
#6
Prev: #—
|
4.6 | 400,000 | no change |
NEW
|
400,000 | $13,264,000 | 2002 Q4 | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | |||
|
WYE
Wyeth ...
|
Unknown | 6.36% | — |
#7
Prev: #—
|
4.5 | 348,000 | no change |
NEW
|
348,000 | $13,015,200 | 2002 Q4 | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | |||
|
MEDI
Medimmune Inc. ...
|
Unknown | 5.84% | — |
#8
Prev: #—
|
4.3 | 440,000 | no change |
NEW
|
440,000 | $11,954,800 | 2002 Q4 | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | |||
|
GENZ
General Divisio...
|
Unknown | 5.78% | — |
#9
Prev: #—
|
4.3 | 400,000 | no change |
NEW
|
400,000 | $11,828,000 | 2002 Q4 | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | |||
|
GILD
Gilead Sciences...
|
Healthcare | 5.31% | — |
#10
Prev: #—
|
4.1 | 320,000 | no change |
NEW
|
320,000 | $10,880,000 | 2002 Q4 | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | |||
|
IDPH
Pharmaceuticals...
|
Unknown | 4.13% | — |
#11
Prev: #—
|
3.7 | 255,000 | no change |
NEW
|
255,000 | $8,458,350 | 2002 Q4 | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | |||
|
LIFC
Lifecell ...
|
Unknown | 2.42% | — |
#12
Prev: #—
|
3.0 | 1,644,320 | no change |
NEW
|
1,644,320 | $4,949,403 | 2002 Q4 | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | |||
|
N/A
Laboratories In...
|
—
|
Unknown | 2.27% | — |
#13
Prev: #—
|
2.9 | 1,652,892 | no change |
NEW
|
1,652,892 | $4,644,626 | — | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | ||
|
N/A
Adolor Corp. ...
|
—
|
Unknown | 2.14% | — |
#14
Prev: #—
|
2.9 | 315,000 | no change |
NEW
|
315,000 | $4,381,650 | — | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | ||
|
SEPR
Sepracor Inc. ...
|
Unknown | 1.84% | — |
#15
Prev: #—
|
2.7 | 390,000 | no change |
NEW
|
390,000 | $3,771,300 | 2002 Q4 | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | |||
|
N/A
Depomed Inc. ...
|
—
|
Unknown | 1.71% | — |
#16
Prev: #—
|
2.7 | 1,755,050 | no change |
NEW
|
1,755,050 | $3,510,100 | — | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | ||
|
AFFX
Affymetrix Inc ...
|
Unknown | 1.68% | — |
#17
Prev: #—
|
2.7 | 150,000 | no change |
NEW
|
150,000 | $3,433,500 | 2002 Q4 | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | |||
|
N/A
SangStat Medica...
|
—
|
Unknown | 1.24% | — |
#18
Prev: #—
|
2.5 | 225,000 | no change |
NEW
|
225,000 | $2,542,500 | — | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | ||
|
N/A
Bioenvision, In...
|
—
|
Unknown | 1.04% | — |
#19
Prev: #—
|
2.4 | 1,367,818 | no change |
NEW
|
1,367,818 | $2,120,118 | — | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | ||
|
CIPH
Ciphergen Biosy...
|
Unknown | 1.01% | — |
#20
Prev: #—
|
2.4 | 600,000 | no change |
NEW
|
600,000 | $2,070,000 | 2002 Q4 | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | |||
|
ALXN
Pharmaceuticals...
|
Unknown | 1.01% | — |
#21
Prev: #—
|
2.4 | 146,100 | no change |
NEW
|
146,100 | $2,062,932 | 2002 Q4 | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | |||
|
ABGX
Abgenix Inc. ...
|
Unknown | 0.99% | — |
#22
Prev: #—
|
2.4 | 275,000 | no change |
NEW
|
275,000 | $2,026,750 | 2002 Q4 | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | |||
|
INCY
Incyte Pharma ...
|
Healthcare | 0.89% | — |
#23
Prev: #—
|
2.4 | 400,000 | no change |
NEW
|
400,000 | $1,824,000 | 2002 Q4 | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | |||
|
N/A
Bio-Technology ...
|
—
|
Unknown | 0.79% | — |
#24
Prev: #—
|
2.3 | 504,500 | no change |
NEW
|
504,500 | $1,614,904 | — | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) | ||
|
GPRO
GenProbe ...
|
Technology | 0.67% | — |
#25
Prev: #—
|
2.3 | 58,050 | no change |
NEW
|
58,050 | $1,381,532 | 2002 Q4 | 13F Filing | 2002-12-31 | 2003-02-14 (Est.) |
Showing 1-25 of 28 holdings